International Ophthalmology

, Volume 30, Issue 3, pp 303–305

Mitomycin C in the treatment of a Schneiderian (inverted) papilloma of the lacrimal sac

Authors

  • Malcolm Woodcock
    • Birmingham and Midland Eye CentreCity Hospital
    • Division of OphthalmologyGroote Schuur Hospital and University of Cape Town
    • Birmingham and Midland Eye CentreCity Hospital
  • Dale Harrison
    • Division of OphthalmologyGroote Schuur Hospital and University of Cape Town
  • Deryck Taylor
    • Division of Anatomical PathologyGroote Schuur Hospital and University of Cape Town
  • Karin Lecuona
    • Division of OphthalmologyGroote Schuur Hospital and University of Cape Town
Case Report

DOI: 10.1007/s10792-009-9314-y

Cite this article as:
Woodcock, M., Mollan, S.P., Harrison, D. et al. Int Ophthalmol (2010) 30: 303. doi:10.1007/s10792-009-9314-y

Abstract

Schneiderian papillomas are benign tumours, with an aggressive nature. A case with a recurrent Schneiderian papilloma of the nasolacrimal sac, who underwent an external dacryocystorhinostomy (DCR) with irrigation of the nasolacrimal system with 0.02% mitomycin C (MMC), is presented at 18 months follow-up. External DCR using MMC, as an adjuvant therapy, is a novel approach to the treatment of Schneiderian papilloma of the nasolacrimal tract. It allows preservation of function, compared with the conventional treatment of dacryocystectomy.

Keywords

DacrocystorhinostomyMitomycin CPapilloma, invertedSchneiderian papilloma

Abbreviations

DCR

Dacryocystorhinostomy

MMC

Mitomycin C

Copyright information

© Springer Science+Business Media B.V. 2009